Skip to main content
. 2013 Feb 1;14(2):117–126. doi: 10.4161/cbt.22633

graphic file with name cbt-14-117-g2.jpg

Figure 2. Effects of dasatinib and sunitinib on Cav-1 expression and secretion and on TK signaling in DU145 cells. Dasatinib (A) and sunitinib (B) treatment of DU145 cells resulted in a dose-dependent decrease in phosphorylation of PDGFRβ, VEGFR2, Src and Cav-1. Dasatinib, but not sunitinib, also reduced the phosphorylation of FAK and Akt. Both dasatinib and sunitinib dose-dependently reduced significantly the secretion of Cav-1.